Michael A Metzger insider trades: Syndax Pharmaceuticals (SNDX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | SNDX | ↓ Sell | 32,375 | $24.24 | $785K | Direct | Jul 9, 2026 (1d) |
| Jun 1, 2026 | SNDX | ↓ Sell | 6,847 | $18.99 | $130K | Direct | Jun 2, 2026 (1d) |
| Feb 9, 2026 | SNDX | ↓ Sell | 17,159 | $21.03 | $361K | Direct | Feb 10, 2026 (1d) |
| Feb 6, 2026 | SNDX | ↓ Sell | 7,412 | $20.62 | $153K | Direct | Feb 6, 2026 (0d) |
| Sep 8, 2025 | SNDX | ↓ Sell | 157,307 | $16.41 | $2.6M | Direct | Sep 8, 2025 (0d) |
| Jul 16, 2025 | SNDX | ↓ Sell | 7,534 | $9.29 | $70K | Direct | Jul 18, 2025 (2d) |
| Mar 4, 2025 | SNDX | ↓ Sell | 7,814 | $15.05 | $118K | Direct | Mar 6, 2025 (2d) |
| Feb 10, 2025 | SNDX | ↓ Sell | 13,288 | $15.50 | $206K | Direct | Feb 12, 2025 (2d) |
| Feb 6, 2023 | SNDX | ↓ Sell | 5,959 | $27.64 | $165K | Direct | Feb 8, 2023 (2d) |
| Nov 8, 2022 | CTIC | ↓ Sell | 91,500 | $5.58 | $511K | Direct | Nov 10, 2022 (2d) |
| Oct 6, 2022 | SNDX | ↓ Sell | 16,231 | $25.29 | $411K | Direct | Oct 7, 2022 (1d) |
| Oct 4, 2022 | SNDX | ↓ Sell | 33,769 | $25.02 | $845K | Direct | Oct 4, 2022 (0d) |
| Jul 25, 2022 | SNDX | ↓ Sell | 31,602 | $21.06 | $665K | Direct | Jul 27, 2022 (2d) |
| Jul 7, 2022 | CTIC | ↓ Sell | 20,121 | $6.51 | $131K | Direct | Jul 11, 2022 (4d) |
| Jul 7, 2022 | SNDX | ↓ Sell | 15,109 | $21.07 | $318K | Direct | Jul 8, 2022 (1d) |
| Jul 5, 2022 | CTIC | ↓ Sell | 91,500 | $6.08 | $556K | Direct | Jul 7, 2022 (2d) |
| Dec 20, 2021 | SNDX | ↓ Sell | 85,391 | $19.94 | $1.7M | Direct | Dec 20, 2021 (0d) |
| Dec 13, 2021 | SNDX | ↓ Sell | 36,609 | $19.05 | $698K | Direct | Dec 15, 2021 (2d) |
| Oct 26, 2021 | SNDX | ↓ Sell | 61,000 | $19.15 | $1.2M | Direct | Oct 27, 2021 (1d) |
| Sep 27, 2021 | SNDX | ↓ Sell | 24,437 | $19.51 | $477K | Direct | Sep 28, 2021 (1d) |
| Sep 22, 2021 | SNDX | ↓ Sell | 36,563 | $19.22 | $703K | Direct | Sep 22, 2021 (0d) |
| Sep 14, 2021 | SNDX | ↓ Sell | 61,000 | $19.12 | $1.2M | Direct | Sep 15, 2021 (1d) |
| Feb 1, 2021 | SNDX | ↓ Sell | 15,000 | $20.19 | $303K | Direct | Feb 3, 2021 (2d) |
| Dec 1, 2020 | SNDX | ↓ Sell | 15,000 | $22.97 | $345K | Direct | Dec 3, 2020 (2d) |
| Nov 4, 2020 | SNDX | ↓ Sell | 100,000 | $20.31 | $2.0M | Direct | Nov 6, 2020 (2d) |
| Feb 2, 2012 | RGDX | ↑ Buy | 1,000 | $1.50 | $2K | Direct | Feb 6, 2012 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SNDX insiders
Open-market trades in the last 12 months
About Michael A Metzger's insider trades
Michael A Metzger is Chief Executive Officer at Syndax Pharmaceuticals (SNDX). Since Feb 2, 2012, Michael has reported 1 open-market purchase worth $2K and 25 sales worth $16.6M on SEC Form 4. In the last 12 months: 4 sales ($1.4M).
Their filings also include grants and awards (28 filings), option exercises (21 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.